1. India Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: major
Bandaram Pharma Packtech Limited

Bandaram Pharma Packtech Limited

BBSE:BANDARAM
19.00
INR
-0.24
(-1.25%)
0.74EPS
45.62P/E
512.20MMarket Cap
Bandaram Pharma Packtech Limited
BSE:BANDARAM
(Bombay Stock Exchange)

Recent

price

19.00

P/E

ratio

45.62

div

yld

- -

ROIC.AI

2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2021
2022
2023
2024
2025
2026
TTM
INR
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
62.44
28.4
30.8
35.01
49.39
Revenue per Share
-9.3
-0.9
-0.59
-1.25
-5.24
-1.34
-469.72
-2.64
-16.67
-17.74
-0.48
-0.5
0.86
0.43
0.83
0.16
0.62
Basic EPS, GAAP
- -
-0.29
- -
-14.05
-11.07
-1.34
-1.34
-14.17
-20.33
-15.22
- -
144.3
-12.98
-3.59
-4.18
-2.74
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.2
- -
- -
Dividend per Share
-52.81
-53.72
-54.3
-56.3
-61.54
-62.89
-62.78
-65.42
-9.46
-27.2
-35.42
3.47
3.58
10.23
10.54
14.9
- -
Book Value per Share
-52.81
-53.72
-54.3
-56.3
-61.54
-62.89
-62.78
-65.42
-9.69
-27.4
-35.42
3.47
3.58
10.23
10.54
11.67
- -
Tangible Book Value per Share
- -
- -
- -
- -
- -
- -
- -
- -
1
1
1
- -
3
12
12
18
16
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
187
341
370
629
788
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
3.8
6.2
5.98
3.51
3.93
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
6
7
6
10
7
Depreciation Expense
-2
- -
- -
- -
-1
- -
-85
- -
-11
-12
- -
- -
3
5
10
3
10
Net Income, GAAP
- -
- -
- -
- -
- -
- -
423,347.5
- -
- -
- -
- -
- -
20.92
20.13
24.48
36.26
28.12
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1.37
1.53
2.69
0.45
1.26
Profit Margin (%)
-4
-4
-8
-9
-11
-12
-12
-1
5
-2
-4
30
77
138
168
227
- -
Working Capital
6
6
6
- -
- -
- -
- -
4
8
12
15
- -
76
47
90
101
- -
LT Debt
-10
-10
-10
-10
-11
-11
-11
-12
-6
-18
-23
30
51
151
158
314
- -
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
5.02
7.15
5.47
2.76
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
14,729.82
- -
- -
- -
- -
- -
3.71
2.51
3.84
2.21
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
8.48
6.79
7.97
1.43
- -
Return on Common Equity (%)

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
139
- -
LT Borrowings
- -
101
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
17
18
18
Market Capitalization
520
423
512

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
570
- -
Cash, Cash Equivalents & STI
- -
7
- -
Accounts Receivable, Net
- -
313
- -
Inventories
- -
129
- -
Total Current Liabilities
- -
343
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
139
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
31.37%
27.9%
98.27%
Free Cash Flow
- -
- -
-1.78%
Net Income, GAAP
3,425.25%
-517.01%
-71.7%
Sales/Revenue/Turnover
- -
- -
70.23%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
114
71
100
85
370
2026
81
137
148
263
629
2027
240
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
0.15
0.31
-0.01
0.13
0.83
2026
0.02
0.03
0.11
0.05
0.16
2027
0.38
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
0.2
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -
Similar Companies
Eli Lilly and Company (NYSE:LLY)
Novo Nordisk A/S (NYSE:NVO)
Johnson & Johnson (NYSE:JNJ)
Pfizer, Inc. (NYSE:PFE)
Dr. Reddy's Laboratories Ltd. (NSE:DRREDDY)
Divi's Laboratories Limited (NSE:DIVISLAB)
Business
Bandaram Pharma Packtech Limited, formerly known as Shiva Medicare Limited, is an India-based company engaged in the manufacturing, processing, trading, and supply of pharmaceutical packaging solutions, specialized packaging materials, and healthcare-related products. Founded in 1993 and headquartered in Hyderabad, Telangana, India, the company serves the pharmaceutical, nutraceutical, biotechnology, and fast-moving consumer goods (FMCG) industries. Its core product and service portfolio includes rigid and flexible packaging materials; primary packaging solutions, such as plastic bottles, containers, vials, caps, and closures; secondary packaging products, including printed paperboard cartons, corrugated boxes, and outer shippers; blister packs, aluminium foil laminates, and strip packaging for solid dosage forms; barrier films, pouches, and tamper-evident sealing solutions; as well as customized contract packaging, labeling, and converting services tailored to domestic regulatory standards. In recent developments, the company executed a strategic corporate restructuring and name change to Bandaram Pharma Packtech Limited to reposition its operations around high-growth pharmaceutical packaging technology. The company has also advanced capital restructuring and promoter alignment initiatives, modernized its manufacturing and distribution capabilities, and expanded its portfolio toward sustainable, recyclable, and barrier-enhanced packaging formats to support increasing demand from formulation manufacturers across India.